Page 7 - Patrickj Haley News Today

Nordea Investment Management AB reduced its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 300,393 shares of the biotechnology company’s stock after selling 3,828 shares during the […]

Exelixis, Inc. (NASDAQ:EXEL – Get Rating) – Research analysts at William Blair upped their Q1 2022 earnings per share (EPS) estimates for shares of Exelixis in a report issued on Monday, March 14th. William Blair analyst A. Hsieh now expects that the biotechnology company will post earnings of $0.20 per share for the quarter, up […]

LPL Financial LLC boosted its stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 70.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 63,251 shares of the biotechnology company’s stock after purchasing an additional 26,188 shares during the period. LPL Financial LLC’s holdings in Exelixis were worth […]

Exelixis (NASDAQ:EXEL – Get Rating) had its target price lowered by equities researchers at Piper Sandler from $34.00 to $30.00 in a report issued on Monday, The Fly reports. Piper Sandler’s price objective would indicate a potential upside of 45.70% from the stock’s previous close. A number of other analysts have also commented on EXEL. […]

Louisiana State Employees Retirement System boosted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,400 shares of the biotechnology company’s stock after purchasing an additional 1,000 […]

EXEL earnings call for the period ending September 30, 2021.